803232-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001596-ETANERCEPT 50 MG/1 ML SOL INJ BIOSSIMILAR CANETA ( BENEPALI )

World Biggest Tenders Source

This tender with title 803232-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001596-ETANERCEPT 50 MG/1 ML SOL INJ BIOSSIMILAR CANETA ( BENEPALI ) -- Contract Value: 467 040,00 EUR has been published on Bidding Source portal dated 09 Dec 2025 for the country of Portugal. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 467 040,00 EUR

General Information

Portugal

Tender Title :

803232-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001596-ETANERCEPT 50 MG/1 ML SOL INJ BIOSSIMILAR CANETA ( BENEPALI )
Contract Value: 467 040,00 EUR

Tender Type :

Contract Award

Reference No. :

803232

Country :

Portugal

Publish Date :

9 Dec 2025

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic and immunomodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

856245-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - ACALABRUTINIB [100 MG CÁP/COMP] Portugal 856304-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP] Portugal 857955-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS] Portugal 858176-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS] Portugal 858185-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - ACALABRUTINIB [100 MG CÁP/COMP] Portugal 858670-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS] Portugal 859638-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP] Portugal 857350-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP] Portugal 832865-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] Portugal 832999-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal

803232-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001596-ETANERCEPT 50 MG/1 ML SOL INJ BIOSSIMILAR CANETA ( BENEPALI )

Contract Value: 467 040,00 EUR

General Information

Portugal

Similar Tenders

Antineoplastic and immunomodulating agents Tenders

Portugal Tenders

Europe Tenders

Tenders

info@biddingsource.com